Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05734716 · ClinicalTrials.gov registry record · Phase 4
Colorado-Oregon Altitude Study
A Phase 4 study, sponsored by University of Oregon.
- Completed
- Registry status
- Phase 4
- Development phase
- 121
- Enrollment target
NCT05734716 is a Phase 4 study that has completed, run by University of Oregon. The registered enrollment target is 121 participants.
The verdict
NCT05734716, a Phase 4 study, has completed, sponsored by University of Oregon.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 121 participants
- Enrollment target
Study Summary
Investigating the utility of prophylactic treatment with iron sucrose and/or erythropoietin on the prevention of acute mountain sickness in fit, young, healthy individuals.
Interventions
- DRUG Sterile Sodium Chloride
- DRUG Erythropoietin
- DRUG Iron sucrose (Venofer)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2021-02-17 |
| Est. Completion | 2023-01-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05734716
The ClinicalTrials.gov registry entry for NCT05734716 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oregon, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sterile Sodium Chloride is the first listed.
NCT05734716 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05734716 about?
NCT05734716 is a clinical study titled "Colorado-Oregon Altitude Study". Investigating the utility of prophylactic treatment with iron sucrose and/or erythropoietin on the prevention of acute mountain sickness in fit, young, healthy individuals.
What is the current status of trial NCT05734716?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 121 participants. The study started on 2021-02-17. Estimated completion is 2023-01-01.
What interventions are being tested in trial NCT05734716?
The interventions under investigation include: Sterile Sodium Chloride (DRUG), Erythropoietin (DRUG), Iron sucrose (Venofer) (DRUG).
Who is sponsoring clinical trial NCT05734716?
This trial is sponsored by University of Oregon, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.